Isoindole-imide compounds and compositions comprising and methods of using the same
申请人:Muller W. George
公开号:US20070049618A1
公开(公告)日:2007-03-01
This invention relates to isoindole-imide compounds, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.
User- and eco-friendly hypervalent iodine reagent and method of synthesis
申请人:——
公开号:US20040030187A1
公开(公告)日:2004-02-12
The present invention is a user- and eco-friendly hypervalent iodine reagent (mIBX) capable of selectively oxidizing allylic and benzylic alcohols in water and other eco-friendly solvents and having generally the following structure:
1
Allylic and benzylic alcohols are cleanly oxidized to the corresponding carbonyl compounds in water or water-THF mixtures, or other mixtures, using a water-soluble o-iodoxybenzoic acid derivative of the present invention.
[EN] PHTHALAZINES AS POTASSIUM ION CHANNEL INHIBITORS<br/>[FR] PHTHALAZINES SERVANT D'INHIBITEURS DES CANAUX IONIQUES POTASSIQUES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2014143608A1
公开(公告)日:2014-09-18
A compound of formula (I), wherein A, R1, R3, and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
Crystal structure of 1,1′-biphenyl-2,2′,3,3′-tetracarboxylic and 1,1′-biphenyl-2,2′,3,3′,5,5′,6,6′-octacarboxylic acids: solid-state chiralization and dissociation
X-ray diffraction analysis revealed unexpected stereochemical features accompanying crystal self-assembly of the two title oligocarboxylic acids.
X射线衍射分析揭示了伴随两个标题低聚羧酸的晶体自组装的出乎意料的立体化学特征。
4'-O- substituted isoindoline derivatives and compositions comprising and methods of using the same
申请人:Ruchelman Alexander L.
公开号:US20090004209A1
公开(公告)日:2009-01-01
Provided are 4′-O substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.